It has been a surprising about-turn for growth stocks this year after the mauling that this segment experienced in 2022. The NASDAQ Composite Index and S&P 500 saw declines of 33.1% and 19.4%, respectively, last year. Both the S&P 500 and the bellwether technology index have performed well year-to-date, rising by 17.7% and 33.7% respectively and almost erasing last year’s losses. Along the way, many growth stocks have seen their share prices shoot to a 52-week high. This performance did not happen in isolation as these companies’ earnings have also improved, thereby justifying the rise. We turn the spotlight on four such US stocks to determine if their run can be sustained for the remainder of this year. McKesson Corp (NYSE: MCK) McKesson Corporation is a diversified healthcare services provider that works with biopharmaceutical companies, pharmacies, care providers and governments to deliver quality healthcare products and services. Shares of the healthcare player have risen by 14.3% year-to-date and are hovering close to their 52-week high of US$437.74....